Anti-clotting drugs yield similar results The first trial to review patients with acute coronary syndrome who usually do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists xenical norge orlistatindia.com . The study also demonstrated no difference in serious bleeding problems. Simultaneously, the Duke experts observed an urgent reduction in coronary attack, death and stroke among sufferers treated with prasurgrel beyond one year of treatment.

xenical chemist

The authors explain that, as the absolute risk of suicide is usually low, the widespread usage of SSRIs makes this a inhabitants health concern. In addition they warn that major restrictions in the published trials may have led to underestimates of the chance of suicide attempts. The second study examined 477 trials submitted by drug companies to the safety review of the Medicines and Healthcare items Regulatory Company . These trials compared SSRIs with placebo in adults with depression and other clinical conditions. The extensive research team found no evidence that SSRIs increased the risk of suicide. They found weak evidence of an increased risk of self harm, but no evidence of an increased risk of suicidal thoughts.